divendres, 6 de febrer del 2015

The Pfizer-Hospira Deal: Do Pharma and Device Companies Need Each Other?




Does the transformation of Hospira into more or less a pharma company a declaration of defeat for the medtech industry?





Pfizer offers $15 billion for Hospira

By Amy Siegel, S2N Health


Having been at the flag-raising ceremony for Hospira when it spun out of Abbott back in 2004, the news of Pfizer’s acquisition was a bit emotional for me. I didn’t cry or anything, but I did feel a little sad, and a little proud, and maybe a little hopeful at the end of the day.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1LVP3Yf

Cap comentari:

Publica un comentari a l'entrada